Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1.
MACC1 (Metastasis Associated in Colon Cancer 1) is a key driver and prognostic biomarker for cancer progression and metastasis in a large variety of solid tumor types, particularly colorectal cancer (CRC). However, no MACC1 inhibitors have been identified yet. Therefore, we aimed to target MACC1 exp...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-06-01
|
Series: | PLoS Biology |
Online Access: | http://europepmc.org/articles/PMC5453412?pdf=render |